psoriasis
PSORIASIS

Psoriasis is a systemic chronic skin disorder characterized by excessive keratinocyte proliferation that results into thickened scaly plaques, itching and inflammatory changes in the epidermis and dermis. It is transmitted genetically but can be provoked by environmental factors.
It is found in approximately 2% of the population that primarily affects the skin and joints.
It is associated with other inflammatory disorders and autoimmune diseases (eg psoriatic arthritis, inflammatory bowel disease, coronary artery disease).
Generally, it begins as red scaling papules that coalesce to form round-to-oval plaques. The rashes are often pruritic and may be painful.

Psoriasis Drug Information

Drug Information

Indication: Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy....

Indication: Signs & symptoms & inhibiting the progression of structural damage in moderately to severely active rh...

Indication: Prophylaxis of transplant rejection in adult kidney or liver allograft receipients. Kidney or liver allograft ...

Indication: Short-term treatment & intermittent long-term therapy of mild to moderate of atopic dermatitis in non-immu...

Indication: Strengthen skin's protective function; increases moisture & lipid content. Reduces feeling of tautness &am...

Indication: Primary immunosuppression in liver & kidney allograft recipients & liver & kidney allograft reject...

Indication: RA; ankylosing spondylitis; psoriatic arthritis; psoriasis; Crohn's & fistulizing Crohn's disease; ulcerat...

Sebitar
coal tar solution + pine tar + salicylic acid

Indication: Psoriasis, seborrheic dermatitis, seborrhea (including severe dandruff), eczema, itching scalp.

Indication: Moderately to severely active Crohn's disease in adult patients who had inadequate response w/, lost response ...

Indication: Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

1  /  12
Editor's Recommendations
Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 2 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.